Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease (MND)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Ended earlyNCT03196375
What this trial is testing

Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Who this might be right for
Motor Neuron Disease
Flex Pharma, Inc. 54
Not applicableEnded earlyNCT01950910
What this trial is testing

Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)

Who this might be right for
Amyotrophic Lateral Sclerosis
Wake Forest University Health Sciences 766
Not applicableUnknownNCT06566651
What this trial is testing

Emotion Processing Among Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisNeuromuscular DiseasesALS+2 more
University of Aarhus 180
Testing effectiveness (Phase 2)WithdrawnNCT03474263
What this trial is testing

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Implicit Bioscience
Testing effectiveness (Phase 2)Study completedNCT04313166
What this trial is testing

Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

Who this might be right for
Amyotrophic Lateral Sclerosis
Collaborative Medicinal Development Pty Limited 55
Testing effectiveness (Phase 2)Study completedNCT05039268
What this trial is testing

3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Macquarie University, Australia 16
Testing effectiveness (Phase 2)Study completedNCT00409721
What this trial is testing

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Alberta 42
Not applicableNot Yet RecruitingNCT07393932
What this trial is testing

MND Together: Phase 1

Who this might be right for
MND (Motor Neurone DIsease)
University of Sheffield 287
Early research (Phase 1)Study completedNCT02870634
What this trial is testing

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Collaborative Medicinal Development Pty Limited 50
Not applicableUnknownNCT05299372
What this trial is testing

Telemonitoring in NIV MND (OptNIVent)

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Liverpool University Hospitals NHS Foundation Trust 15
Not applicableUnknownNCT03081338
What this trial is testing

A Programme for Amyotrophic Lateral Sclerosis Care in Europe

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)MND (Motor Neurone DIsease)
Sheffield Teaching Hospitals NHS Foundation Trust 115
Testing effectiveness (Phase 2)Study completedNCT00983983
What this trial is testing

High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 28
Not applicableStudy completedNCT02464852
What this trial is testing

Assessment of the Effects of Sheffield Support Snood in MND Patients

Who this might be right for
Motor Neurone Disease
Sheffield Teaching Hospitals NHS Foundation Trust 15
Testing effectiveness (Phase 2)Ended earlyNCT03705390
What this trial is testing

A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University of Birmingham 11
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Not applicableLooking for participantsNCT07533903
What this trial is testing

Functional Outcomes and Control Using Synchron BCI - Australia

Who this might be right for
Neurologic DisorderNeurologic DiseasesMND (Motor Neurone DIsease)+4 more
Synchron, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT03127267
What this trial is testing

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
AB Science 495
Not applicableStudy completedNCT04695210
What this trial is testing

Virtual Peer-to-peer Support Programme for Carers of MND

Who this might be right for
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
King's College London 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT06643481
What this trial is testing

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Novartis Pharmaceuticals 251
Next Page